核仁素
小RNA
基因沉默
微泡
胞外囊泡
癌症研究
小干扰RNA
流式细胞术
外体
乳腺癌
RNA干扰
癌细胞
微泡
癌症
基因传递
生物
细胞生物学
适体
核糖核酸
分子生物学
细胞培养
转染
生物化学
基因
核仁
细胞质
遗传学
作者
Yayu Wang,Xiaojia Chen,Baoqing Tian,Jiafan Liu,Li Yang,Lilan Zeng,Tianfen Chen,An Hong,Xiaogang Wang
出处
期刊:Theranostics
[Ivyspring International Publisher]
日期:2017-01-01
卷期号:7 (5): 1360-1372
被引量:197
摘要
Small interfering RNAs (siRNA)/microRNAs (miRNA) have promising therapeutic potential, yet their clinical application has been hampered by the lack of appropriate delivery systems.Herein, we employed extracellular vesicles (EVs) as a targeted delivery system for small RNAs.EVs are cell-derived small vesicles that participate in cell-to-cell communication for protein and RNA delivery.We used the aptamer AS1411-modified EVs for targeted delivery of siRNA/microRNA to breast cancer tissues.Tumor targeting was facilitated via AS1411 binding to nucleolin, which is highly expressed on the surface membrane of breast cancer cells.This delivery vesicle targeted let-7 miRNA delivery to MDA-MB-231 cells in vitro as confirmed with fluorescent microscopic imaging and flow cytometry.Also, intravenously delivered AS1411-EVs loaded with miRNA let-7 labeled with the fluorescent marker, Cy5, selectively targeted tumor tissues in tumor-bearing mice and inhibited tumor growth.Importantly, the modified EVs were well tolerated and showed no evidence of nonspecific side effects or immune response.Thus, the RNAi nanoplatform is versatile and can deliver siRNA or miRNA to breast cancer cells both in vitro and in vivo.Our results suggest that the AS1411-EVs have a great potential as drug delivery vehicles to treat cancers.
科研通智能强力驱动
Strongly Powered by AbleSci AI